Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pressure Biosciences Inc. PBIO

Pressure BioSciences Inc is engaged in the healthcare division. It focuses on solving the problems inherent in biological sample preparation. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kit, MicroTubes, HUB High-Pressure Generators and Accessories, RF1700 Mini Ultra-High Pressure Pump, High-Pressure Cell Disruptors from Constant Systems, and SHREDDER Tubes, Service Contracts, and others.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

New Press Release - Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference - Annual Revenue to PBI Expected to Exceed $1M

Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A SessionSOUTH EASTON, MA / ACCESSWIRE / July 6, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure...read article.
@ the Bell: Commodities drag TSX stocks lower as recession fears grip global markets
Canada’s main stocks index slid more than 1 per cent on Tuesday, following up a bigger market selloff as global recession worries came to the forefront, while energy stocks dipped along with oil... read article.

Neovasc Announces Direct Sales Operations in United Kingdom

Fred Colen, Neovasc President and Chief Executive Officer, said, “We are pleased to expand our direct presence into the United Kingdom and want to thank our partners at Healthcare 21 for their excellent foundational efforts supporting the early growth of Reducer. We are now poised to provide even deeper support with a full-time dedicated team in the U.K. and intend to continue to invest in clinical research and field personnel to support patients, physicians, and hospitals.” ...read more

CEO Presenting on the Emerging Growth Conference on July 6

The schedule for July 6, 2022, is as follows: (All times are Eastern Time Zone) We may see some schedule changes on Wednesday. To stay current on the schedule, please follow us on Twitter: ...read more
@ the Bell: Markets start second half of '22 trading on upbeat note
Canada’s resources-heavy stock index rose on Monday as oil prices gained and investors returned from a long weekend to purchase riskier assets that have been battered by concerns over a global... read article.

Pressure BioSciences to Participate in FORCE Family Office

SOUTH EASTON, MA / ACCESSWIRE / June 30, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative...read more
Buzz on the Bullboards: Sizzling sector highlights
It has been a sizzling few days recently for most of North America, both weather-wise and for investing discussions. The markets face a rate hike in the U.S., ongoing inflation, rising oil and... read article.

New Press Release - Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products

Investors, Analysts, and Advisors Invited to Attend this Real-Time, Interactive Presentation/Q&A EventSOUTH EASTON, MA / ACCESSWIRE / June 30, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure...read article.

Pressure BioSciences Announces Contracted Production Launch

SOUTH EASTON, MA / ACCESSWIRE / June 29, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling...read more

Pressure BioSciences' Ultra Shear Technology Positioned

SOUTH EASTON, MA / ACCESSWIRE / June 14, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling...read more

New Press Release - Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market

Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI's UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based BeveragesSOUTH EASTON, MA / ACCESSWIRE / June 14, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the...read article.

Pressure BioSciences Discusses Launch of Early Access

Mr. Copley inquired further: "We have certainly been hearing and want to learn more about the successful launch of your UST Early Access Program. Please explain!" "UST, our latest...read more

New Press Release - Pressure BioSciences Discusses Launch of Early Access Program for Ultra Shear Technology for the Processing of Nanoemulsions with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - June 1, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing...read article.

Emerging Technology Insider Releases New TechTalks Video

SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading...read more

New Press Release - Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher

SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading global source for business and financial opportunities of technology companies, has released a new TechTalks video interview...read article.

Pressure BioSciences, Inc. Reports Q1 2022 Financial Results

Financial Highlights: Q1 2022 vs. Q1 2021 (rounded to nearest hundred except EPS) Total revenue for Q1 2022 was $480,000, reduced 14% from $560,000 for Q1 2021. Instrument sales for Q1...read more

New Press Release - Pressure BioSciences, Inc. Reports Q1 2022 Financial Results

Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and CosmeticsInvestor Call Scheduled for Thursday, May 19, 2022 at 4:30 p.m. ETSOUTH EASTON, MA / ACCESSWIRE...read article.

Pressure BioSciences Announces First Nanoemulsions

SOUTH EASTON, MA / ACCESSWIRE / May 4, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling...read more

Pressure BioSciences to Present at the Planet MicroCap

Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am PDT SOUTH EASTON, MA / ACCESSWIRE / May 3, 2022 / ...read more

Pressure BioSciences Announces Early Access Program for UST

SOUTH EASTON, MA / ACCESSWIRE / April 27, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling...read more

Pressure BioSciences, Inc. Discusses Commercialization

Mr. Jolly began the interview by asking: "Could you please give my audience an update on the progress Pressure BioSciences is making towards the commercial release of your UST platform later this...read more

Pressure BioSciences, Inc. Discusses Commercialization

Phoenix, Arizona--(Newsfile Corp. - April 20, 2022) - The Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company"), a leader in the development...read more

Pressure BioSciences to Discuss Recent Achievements

Company Invites Investors, Analysts, and Advisors to Attend Its Virtual Presentation on Wednesday, April 20th at 10:30am EDT SOUTH EASTON, MA / ACCESSWIRE / April 19, 2022 / Pressure...read more

Pressure BioSciences Leveraging Strong FY2021 Operational

Financial Results: Q4 2021 vs. Q4 2020 Total revenue for Q4 2021 was $315,199 compared to $164,702 for the same period in 2020, a 91% increase. This increase was primarily due to our double-digit...read more